About The Position

Reporting to the Senior Director, Medical Scientific Communications and Content, Vaccines, in this portfolio-wide, cross-pathogen role, you will be responsible for developing and advancing an integrated medical strategy and unified scientific narrative for Pfizer Vaccines, connecting evidence across pathogens and positioning Pfizer as a rigorous scientific reference point in vaccines across all stages of life. You will lead impactful scientific communication strategies, ensure alignment with portfolio and Therapeutic Area priorities, and drive consistent, evidence-based engagement across the vaccines community. You will balance these two equally weighted capability areas across the portfolio and its priority specialties and act as a Subject Matter Expert (SME): Medical Communications and Content: You will lead the portfolio-wide scientific communication and content agenda, translating integrated vaccine science into cohesive publications, congress, and medical-to-medical content. Medical Strategy: You will define and advance the cross-pathogen medical strategy, linking Pfizer’s vaccine platforms, life-course protection, and lifecycle evidence into a coherent framework for priority specialties and shared high-risk patient groups.

Requirements

  • MD with an MPH and at least 4 years of experience in a relevant scientific area, e.g., Medical Affairs, Scientific Communications, Epidemiology, Immunology, Vaccinology, Virology, in a biopharmaceutical, biotech, or agency setting OR PhD with an MPH and at least 5 years of experience in relevant scientific area, e.g., Medical Affairs, Scientific Communications, Epidemiology, Immunology, Vaccinology, Virology, in a biopharmaceutical, biotech, or agency setting
  • Deep scientific grounding in vaccines — including immunology, pathogen biology, and evidence generation across the vaccine lifecycle — sufficient to build cross-pathogen strategy and act as a subject matter expert.
  • Experience developing medical or scientific strategy at an asset, portfolio, above-asset, or franchise level, together with scientific communications and content that support scientific exchange.
  • Experience translating complex scientific data across multiple pathogens or therapeutic areas into clear communications for varied audiences, with a strong track record of written and oral scientific communication, including at scientific conferences.
  • Experience delivering scientific content in a highly regulated environment in a compliant way, including omnichannel formats such as publications, plain language summaries, congress materials, podcasts, and short-form digital articles.
  • A track record of peer-reviewed scientific publications, and experience building credibility and working through influence across cross-functional teams.
  • Permanent work authorization in the United States.

Nice To Haves

  • Experience spanning multiple vaccine pathogens or a broad vaccines portfolio
  • Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

Responsibilities

  • Define and advance an integrated, cross-pathogen medical strategy that links pathogen biology, life-course protection, and evidence generation into one scientific framework for the portfolio.
  • Own and evolve the unified vaccines Scientific Communication Platform, so that product- and Therapeutic Area-level narratives align to the broader scientific story and consistent, evidence-based language flows into every deliverable.
  • Develop cross-pathogen scientific narratives, publications, and congress and medical-to-medical content that connect the science for shared high-risk populations rather than communicating asset by asset.
  • Set cross-pathogen scientific priorities that create a single entry point into priority specialties (for example cardiology, oncology, respiratory, hematology, and infectious disease) and address shared high-risk groups such as older adults and immunocompromised patients.
  • Lead data disclosure and publication plans, partnering with clinical and medical teams during data readouts to shape key messages that reinforce the portfolio narrative.
  • Anticipate scientific, epidemiologic, and policy trends and translate them into strategy, feeding insights on durability, real-world effectiveness, and evolving epidemiology back into portfolio priorities.
  • Advise senior leaders across the Global Business Unit, providing analysis in complex, ambiguous situations and influencing decisions that shape the scientific direction of the vaccines franchise.
  • Partner across Medical, Commercial, and Corporate Communications, and with international medical colleagues, to keep the scientific narrative consistent and ready for local adaptation.
  • Manage budgets, agencies, and off-shore teams for portfolio-level deliverables, forecasting and planning resources across projects.
  • Serve as a trusted scientific point of contact for the portfolio, maintaining current knowledge of inline and pipeline assets, relevant pathogen biology, and associated policy issues.

Benefits

  • 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution
  • paid vacation, holiday and personal days
  • paid caregiver/parental and medical leave
  • health benefits to include medical, prescription drug, dental and vision coverage
  • Relocation assistance may be available based on business needs and/or eligibility.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service